title: [Surveillance after prostate cancer radiotherapy].
abstract: Follow-up after prostate cancer radiotherapy aims at detecting local or metastatic relapse, as well as long-term toxicity, requiring adapted treatments. Several scientific societies have published guidelines including clinical, biological and imaging recommendations. More data suggest a role for aggressive salvage therapy in case of local failure following radiotherapy. An adequate follow-up is required for the sake of patients' safety, i.e. to a posteriori validate dose constraints and radiation technique in each radiotherapy department.
authors.affiliation: Service de radiothérapie, institut de cancérologie de l'Ouest René-Gauducheau, boulevard Jacques-Monod, 44805 Nantes-Saint-Herblain, France. s-supiot@nantes.fnclcc.fr
authors.forename: S
authors.initials: S
authors.lastname: Supiot
authors.forename: E
authors.initials: E
authors.lastname: Rio
authors.forename: K
authors.initials: K
authors.lastname: Clément-Colmou
authors.forename: O
authors.initials: O
authors.lastname: Bouchot
authors.forename: J
authors.initials: J
authors.lastname: Rigaud
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000532:radiotherapy* / Q000601:surgery; D000359:Aftercare; D000728:Androgens; D001918:Brachytherapy / Q000009:adverse effects; D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000209:etiology; D005500:Follow-Up Studies; D006727:Hormone Antagonists / Q000627:therapeutic use; D006801:Humans; D007422:Intestines / Q000528:radiation effects; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis / Q000209:etiology; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000209:etiology; D009919:Orchiectomy; D058958:Organs at Risk; D010173:Palpation; D011159:Population Surveillance; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000532:radiotherapy* / Q000601:surgery; D011832:Radiation Injuries / Q000209:etiology / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects; D012008:Recurrence; D016879:Salvage Therapy; D014551:Urinary Tract / Q000528:radiation effects
chemical_list: D000728:Androgens; D006727:Hormone Antagonists; D017430:Prostate-Specific Antigen